Autistic disorder
Conditions
Interventions
Experimental group: 40 autistic patients that will undergo to dental treatment under general anestesia.They will receive by oral route Midazolam (0,5 mg/kg, maximum 15 mg), Ketamine (3 mg/kg,maximum 3
Drug
Sponsors
Hospital Alberto Rassi- HGG
Hospital Alberto Rassi- HGG
Eligibility
Age
2 Years to 59 Years
Inclusion criteria
Inclusion criteria: Autistic disorder; dental treatment; general anestesia; physical condition ASA I and II
Exclusion criteria
Exclusion criteria: Lack of consent, cardiac diseases, prediction of difficult airway, renal disease, alergy or previous adverse reaction to medications of the study, impossibility to give the medication completely
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Higher frequency of greater levels of sedation in the midazolam plus cetamine's group than midazolam alone, assessed by Ramsay' Scale, thirty minuts after oral administration of medications. | — |
Secondary
| Measure | Time frame |
|---|---|
| Higher frequency of minimum reaction or any reaction of the patient at the moment of venous access before induction of general anestesia. | — |
Countries
Brazil
Contacts
Public ContactHeber;Heber Penna;Penna
Hospital Alberto Rassi- HGG;Heber de Moraes Penna
Outcome results
None listed